Topic-focused bibliography: Syringe exchange: HIV prevention, key findings, and future directions

Denise Paone, Don Des Jarlais, Rebecca Gangloff, Judith Milliken, Samuel R. Friedman

Research output: Contribution to journalArticle

Abstract

HIV among injecting drug users (IDUs) has now been documented in over 60 countries in the world, and there are an additional 40 countries where injecting drug use has been reported including widespread epidemics in Southeast and southern Asia and in Latin America. At present HIV infection is almost always fatal, and there is no promise that a preventive vaccine will become available soon. Given the enormity of the HIV epidemic among IDUs and the critical need to reduce the spread of HIV transmission to and from IDUs, prevention efforts are essential. Syringe-exchange programs have become a major component of HIV prevention strategies in most developed countries and work within the philosophy of harm reduction. Increasing access to sterile syringes has been met with considerable controversy. Opponents of syringe exchange have generally argued that increasing access to sterile syringes would simultaneously increase the number of injecting drug users, increase the frequency of injection for already active IDUs, and appear to "condone" an illegal behavior. To date many research studies and four major reviews of syringe exchange literature have been conducted. All studies thus far have shown no increase in illicit drug injection associated with syringe exchanges, and significant decrease in drug risk behaviors.

Original languageEnglish (US)
Pages (from-to)1647-1683
Number of pages37
JournalSubstance Use and Misuse
Volume30
Issue number12
DOIs
StatePublished - Jan 1 1995

Fingerprint

Syringes
Bibliography
Drug Users
bibliography
HIV
drug
Needle-Exchange Programs
Harm Reduction
Southeastern Asia
Injections
Latin America
Street Drugs
Risk-Taking
Developed Countries
Pharmaceutical Preparations
HIV Infections
Vaccines
Direction compound
risk behavior
drug use

Keywords

  • HIV policy
  • HIV prevention
  • IDUs
  • Risk reduction
  • Syringe exchange

ASJC Scopus subject areas

  • Health(social science)
  • Medicine (miscellaneous)
  • Public Health, Environmental and Occupational Health
  • Psychiatry and Mental health

Cite this

Topic-focused bibliography : Syringe exchange: HIV prevention, key findings, and future directions. / Paone, Denise; Des Jarlais, Don; Gangloff, Rebecca; Milliken, Judith; Friedman, Samuel R.

In: Substance Use and Misuse, Vol. 30, No. 12, 01.01.1995, p. 1647-1683.

Research output: Contribution to journalArticle

Paone, Denise ; Des Jarlais, Don ; Gangloff, Rebecca ; Milliken, Judith ; Friedman, Samuel R. / Topic-focused bibliography : Syringe exchange: HIV prevention, key findings, and future directions. In: Substance Use and Misuse. 1995 ; Vol. 30, No. 12. pp. 1647-1683.
@article{95cddae21743490486bb28da5e4f2146,
title = "Topic-focused bibliography: Syringe exchange: HIV prevention, key findings, and future directions",
abstract = "HIV among injecting drug users (IDUs) has now been documented in over 60 countries in the world, and there are an additional 40 countries where injecting drug use has been reported including widespread epidemics in Southeast and southern Asia and in Latin America. At present HIV infection is almost always fatal, and there is no promise that a preventive vaccine will become available soon. Given the enormity of the HIV epidemic among IDUs and the critical need to reduce the spread of HIV transmission to and from IDUs, prevention efforts are essential. Syringe-exchange programs have become a major component of HIV prevention strategies in most developed countries and work within the philosophy of harm reduction. Increasing access to sterile syringes has been met with considerable controversy. Opponents of syringe exchange have generally argued that increasing access to sterile syringes would simultaneously increase the number of injecting drug users, increase the frequency of injection for already active IDUs, and appear to {"}condone{"} an illegal behavior. To date many research studies and four major reviews of syringe exchange literature have been conducted. All studies thus far have shown no increase in illicit drug injection associated with syringe exchanges, and significant decrease in drug risk behaviors.",
keywords = "HIV policy, HIV prevention, IDUs, Risk reduction, Syringe exchange",
author = "Denise Paone and {Des Jarlais}, Don and Rebecca Gangloff and Judith Milliken and Friedman, {Samuel R.}",
year = "1995",
month = "1",
day = "1",
doi = "10.3109/10826089509104419",
language = "English (US)",
volume = "30",
pages = "1647--1683",
journal = "Substance Use and Misuse",
issn = "1082-6084",
publisher = "Informa Healthcare",
number = "12",

}

TY - JOUR

T1 - Topic-focused bibliography

T2 - Syringe exchange: HIV prevention, key findings, and future directions

AU - Paone, Denise

AU - Des Jarlais, Don

AU - Gangloff, Rebecca

AU - Milliken, Judith

AU - Friedman, Samuel R.

PY - 1995/1/1

Y1 - 1995/1/1

N2 - HIV among injecting drug users (IDUs) has now been documented in over 60 countries in the world, and there are an additional 40 countries where injecting drug use has been reported including widespread epidemics in Southeast and southern Asia and in Latin America. At present HIV infection is almost always fatal, and there is no promise that a preventive vaccine will become available soon. Given the enormity of the HIV epidemic among IDUs and the critical need to reduce the spread of HIV transmission to and from IDUs, prevention efforts are essential. Syringe-exchange programs have become a major component of HIV prevention strategies in most developed countries and work within the philosophy of harm reduction. Increasing access to sterile syringes has been met with considerable controversy. Opponents of syringe exchange have generally argued that increasing access to sterile syringes would simultaneously increase the number of injecting drug users, increase the frequency of injection for already active IDUs, and appear to "condone" an illegal behavior. To date many research studies and four major reviews of syringe exchange literature have been conducted. All studies thus far have shown no increase in illicit drug injection associated with syringe exchanges, and significant decrease in drug risk behaviors.

AB - HIV among injecting drug users (IDUs) has now been documented in over 60 countries in the world, and there are an additional 40 countries where injecting drug use has been reported including widespread epidemics in Southeast and southern Asia and in Latin America. At present HIV infection is almost always fatal, and there is no promise that a preventive vaccine will become available soon. Given the enormity of the HIV epidemic among IDUs and the critical need to reduce the spread of HIV transmission to and from IDUs, prevention efforts are essential. Syringe-exchange programs have become a major component of HIV prevention strategies in most developed countries and work within the philosophy of harm reduction. Increasing access to sterile syringes has been met with considerable controversy. Opponents of syringe exchange have generally argued that increasing access to sterile syringes would simultaneously increase the number of injecting drug users, increase the frequency of injection for already active IDUs, and appear to "condone" an illegal behavior. To date many research studies and four major reviews of syringe exchange literature have been conducted. All studies thus far have shown no increase in illicit drug injection associated with syringe exchanges, and significant decrease in drug risk behaviors.

KW - HIV policy

KW - HIV prevention

KW - IDUs

KW - Risk reduction

KW - Syringe exchange

UR - http://www.scopus.com/inward/record.url?scp=84907130530&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907130530&partnerID=8YFLogxK

U2 - 10.3109/10826089509104419

DO - 10.3109/10826089509104419

M3 - Article

VL - 30

SP - 1647

EP - 1683

JO - Substance Use and Misuse

JF - Substance Use and Misuse

SN - 1082-6084

IS - 12

ER -